China Approves New Oral GLP-1 Weight-Loss Medicine: What Does It Mean for Malaysia

|
HTM Pharmacy

A new development in weight management

 

Imagine managing your weight with a daily tablet instead of an injection.

For years, medicines such as Ozempic, Wegovy and Mounjaro have attracted attention for their role in managing diabetes and weight. Many people are familiar with these medicines because they are given by injection.

 

But a new development may give patients another option.

On 12 November 2026, China approved orforglipron, an oral medicine developed by Eli Lilly, for weight management in eligible adults. It is the first oral GLP-1 medicine to receive approval for weight management in China. In the United States, the medicine is marketed under the brand name Foundayo. Unlike many familiar weight-management injections, orforglipron is taken as a tablet once a day.

 

This news has raised several questions:

- What exactly is orforglipron?

- How does a GLP-1 tablet work?

- Will tablets eventually replace weight-loss injections?

- Can Malaysians get this medicine?

 

Lets take a closer look.

 

 

  1. What is this new oral GLP-1 medicine?

The medicine approved in China is called orforglipron, developed by Eli Lilly. It belongs to a group of medicines known as GLP-1 receptor agonists. That name may sound complicated, but the basic idea is quite simple. GLP-1 is a natural hormone produced by our body, especially after eating. It helps regulate blood sugar and sends signals to the brain that contribute to the feeling of fullness.

 

GLP-1 medicines work by copying some of the effects of this natural hormone. They can help people:

- Feel full for longer

- Experience less hunger

- Eat smaller portions

- Better control blood sugar levels

 

In simple terms, these medicines help regulate appetite and blood sugar. This is one reason they are used in the treatment of certain patients with type 2 diabetes or obesity, depending on the specific medicine and its approved use.

 

What makes orforglipron different?

 

Although orforglipron works on the same GLP-1 pathway as medicines such as semaglutide, it is not the same medicine. One important difference is how the medicine is made:

- Semaglutide is a peptide-based medicine.

- Orforglipron is a small-molecule, non-peptide medicine.

 

You do not need to remember these scientific terms. The key point is that orforglipron is a different active ingredient, designed to be taken as a tablet once daily. For people who dislike injections, an oral medicine may be a more convenient option. However, taking a tablet does not automatically make a medicine safer or more effective. Its benefits and possible risks still need to be assessed based on clinical evidence and individual health needs.

 

  1. How is an oral GLP-1 different from weight-loss injections?

The most obvious difference is how the medicine is taken.

Many familiar GLP-1-based treatments for weight management are given by injection, while orforglipron is taken by mouth once a day.

 

It is important to understand that an oral GLP-1 medicine is not necessarily just an injection converted into a tablet. Different medicines can have different active ingredients, doses, treatment instructions and clinical results. For example, orforglipron is not an oral version of Ozempic or Wegovy. It is a separate medicine.

 

  1. Will weight-loss injections eventually be replaced by tablets?

Not necessarily.

 

The approval of an oral GLP-1 medicine gives patients another potential treatment option. It does not mean that injections will disappear. Some people may prefer taking a tablet every day, while others may find a weekly injection more convenient. More importantly, the best treatment is not simply the one that is easiest to take.

 

Doctors need to consider several factors, including a person health condition, treatment goals, response to medication and ability to tolerate possible side effects. The results of different medicines also cannot always be compared directly. Clinical studies may involve different participants, doses, treatment periods and research methods.

 

**The most suitable treatment depends on the individual, not just whether the medicine comes as a tablet or an injection.**

 

  1. What does China approval mean for Malaysia?

This is probably one of the most important questions for Malaysian consumers.

 

The short answer is: A medicine approved in China is not automatically approved for sale in Malaysia.

 

Every country has its own medicine registration process. In Malaysia, medicines must meet the relevant regulatory requirements and obtain the necessary registration from the National Pharmaceutical Regulatory Agency (NPRA) before they can be legally marketed. Based on the Malaysian NPRA product information reviewed on 6 November 2026, although oral semaglutide is already available as a registered medicine for type 2 diabetes, it should not automatically be considered an approved oral weight-loss treatment.

 

Similarly, China approval of Orforglipron does not mean that the medicine is currently registered or available for weight management in Malaysia. Medicine registration status can change. Consumers should always check the latest NPRA records before considering any medicine.

 

  1. Should Malaysians be excited about oral GLP-1 medicines?

It is certainly an interesting development.

 

For people who are uncomfortable with injections, a tablet may offer a more convenient way to take treatment. It also shows that researchers are continuing to develop new options for people who need medical support with weight management.

 

However, there are a few important things to remember :

 

**Safety still matters**

A tablet can still cause side effects. Oral medicines are not automatically safer than injectable medicines.

 

**Results may differ between individuals**

The results depend on the specific medicine, dose, treatment duration and how each person responds.

 

**Not everyone needs weight-loss medication**

Prescription weight-management medicines are intended for people who meet specific medical criteria. They are not suitable for everyone who wants to lose a few kilograms.

 

**Long-term health is more important than quick weight loss**

Medication should be part of a broader weight-management plan that may include healthy eating, physical activity and regular medical follow-up.

 

Consumers should also avoid buying unregistered medicines from online sellers or unofficial sources simply because a product has been approved in another country.

 

  1. What should you do if you are considering GLP-1 treatment?

Whether a medicine is taken as a tablet or an injection, starting GLP-1 treatment should involve a proper medical assessment.

 

A doctor or qualified healthcare professional may consider:

- Your current weight and body mass index (BMI)

- Existing health conditions, such as type 2 diabetes or other weight-related complications

- Your medical history and current medications

- Previous attempts at weight management

- Possible risks and reasons why a particular medicine may not be suitable

- The follow-up and monitoring you may need

 

Remember, GLP-1 medicines are prescription treatments, not ordinary slimming products.

Do not start, stop or change your prescribed medication without speaking to your doctor.

If you are considering medical weight management, start by understanding your health needs and discussing suitable options with a qualified healthcare professional.

 

 

## Frequently Asked Questions

 

Is orforglipron the same as Ozempic?

No. Ozempic contains semaglutide, while orforglipron is a different active ingredient developed by Eli Lilly. Both act on the GLP-1 pathway, but they are different medicines.

 

Is the new oral GLP-1 medicine available in Malaysia?

As of the NPRA register review dated 6 November 2026, no registration result was identified for orforglipron (Foundayo). Its approval in China does not automatically allow it to be marketed in Malaysia.

 

Is oral GLP-1 safer than injectable GLP-1?

Not necessarily. The way a medicine is taken does not determine its overall safety. Each medicine has its own possible side effects, precautions and monitoring requirements.

 

Can I replace my Ozempic injection with an oral GLP-1 tablet?

Do not switch or stop your prescribed medicine without consulting your doctor. Different GLP-1 medicines have different active ingredients, doses and treatment instructions.

 

Are all GLP-1 medicines used for weight loss?

No. Some are approved for type 2 diabetes, while others are approved for weight management. The approved use depends on the specific medicine and the regulations in each country.



The future of weight management: More options, but informed decisions matter

 

China approval of orforglipron is an important development in weight management. It introduces another oral option and highlights the continued progress in medical treatment for obesity. However, a new tablet does not remove the need for proper medical assessment, responsible prescribing and long-term lifestyle support.

 

For Malaysians, the most important message is simple:

 

**International approval does not mean a medicine is automatically registered or available in Malaysia.**

 

Before considering any prescription weight-management medicine, check its local registration status and seek advice from a qualified healthcare professional.

 

At HTM Pharmacy, we believe that understanding your health should come before choosing a treatment. Responsible weight management is about more than reducing the number on the weighing scale. It is about making informed decisions that support your long-term health and well-being.

 

*This article is for educational purposes only and does not replace professional medical advice, diagnosis or treatment. Medicine registration status and approved indications may change. Please consult a qualified healthcare professional for advice about your individual health needs.*

Sorry, this item is out of stock.
This item has been saved to your wishlist.



View My Wishlist Continue Shopping